Insider Buying: Cosmos Health Inc. (NASDAQ:COSM) CEO Acquires 147,563 Shares of Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 147,563 shares of Cosmos Health stock in a transaction dated Tuesday, May 20th. The shares were purchased at an average cost of $0.45 per share, for a total transaction of $66,403.35. Following the transaction, the chief executive officer now owns 5,808,883 shares in the company, valued at approximately $2,613,997.35. This trade represents a 2.61% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Grigorios Siokas also recently made the following trade(s):

• On Monday, May 19th, Grigorios Siokas bought 79,254 shares of Cosmos Health stock. The stock was bought at an average price of $0.43 per share, with a total value of $34,079.22.
• On Wednesday, April 23rd, Grigorios Siokas bought 205,000 shares of Cosmos Health stock. The stock was bought at an average price of $0.40 per share, with a total value of $82,000.00.
• On Monday, April 21st, Grigorios Siokas purchased 654,912 shares of Cosmos Health stock. The stock was acquired at an average price of $0.32 per share, with a total value of $209,571.84.
• On Monday, March 3rd, Grigorios Siokas purchased 132,572 shares of Cosmos Health stock. The stock was acquired at an average price of $0.49 per share, with a total value of $64,960.28.
• On Monday, February 24th, Grigorios Siokas purchased 354,296 shares of Cosmos Health stock. The stock was acquired at an average price of $0.56 per share, with a total value of $198,405.76.

Cosmos Health Stock Performance

NASDAQ:COSM opened at $0.47 on Thursday. The company has a market cap of $12.85 million, a price-to-earnings ratio of -0.19 and a beta of 5.50. The company has a fifty day simple moving average of $0.42 and a two-hundred day simple moving average of $0.59. Cosmos Health Inc. has a 52 week low of $0.28 and a 52 week high of $1.58. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings results on Thursday, May 15th. The company reported $0.01 earnings per share for the quarter. Cosmos Health had a negative net margin of 36.39% and a negative return on equity of 9.39%. As a group, equities analysts anticipate that Cosmos Health Inc. will post -0.78 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Cosmos Health stock. Armistice Capital LLC grew its holdings in Cosmos Health Inc. (NASDAQ:COSM) by 156.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,917,710 shares of the company’s stock after purchasing an additional 1,168,884 shares during the quarter. Armistice Capital LLC owned approximately 7.03% of Cosmos Health worth $836,000 at the end of the most recent quarter. 12.61% of the stock is currently owned by institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.